1. Home
  2. CHRS vs ALCO Comparison

CHRS vs ALCO Comparison

Compare CHRS & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRS
  • ALCO
  • Stock Information
  • Founded
  • CHRS 2010
  • ALCO 1960
  • Country
  • CHRS United States
  • ALCO United States
  • Employees
  • CHRS N/A
  • ALCO N/A
  • Industry
  • CHRS Biotechnology: Biological Products (No Diagnostic Substances)
  • ALCO
  • Sector
  • CHRS Health Care
  • ALCO
  • Exchange
  • CHRS Nasdaq
  • ALCO Nasdaq
  • Market Cap
  • CHRS 84.2M
  • ALCO 242.9M
  • IPO Year
  • CHRS 2014
  • ALCO N/A
  • Fundamental
  • Price
  • CHRS $0.83
  • ALCO $32.19
  • Analyst Decision
  • CHRS Buy
  • ALCO
  • Analyst Count
  • CHRS 3
  • ALCO 0
  • Target Price
  • CHRS $4.68
  • ALCO N/A
  • AVG Volume (30 Days)
  • CHRS 1.3M
  • ALCO 57.9K
  • Earning Date
  • CHRS 08-07-2025
  • ALCO 08-04-2025
  • Dividend Yield
  • CHRS N/A
  • ALCO 0.62%
  • EPS Growth
  • CHRS N/A
  • ALCO N/A
  • EPS
  • CHRS N/A
  • ALCO N/A
  • Revenue
  • CHRS $272,251,000.00
  • ALCO $49,419,000.00
  • Revenue This Year
  • CHRS N/A
  • ALCO $22.90
  • Revenue Next Year
  • CHRS $106.56
  • ALCO N/A
  • P/E Ratio
  • CHRS N/A
  • ALCO N/A
  • Revenue Growth
  • CHRS 19.87
  • ALCO 23.36
  • 52 Week Low
  • CHRS $0.66
  • ALCO $24.23
  • 52 Week High
  • CHRS $2.43
  • ALCO $34.31
  • Technical
  • Relative Strength Index (RSI)
  • CHRS 56.33
  • ALCO 54.59
  • Support Level
  • CHRS $0.73
  • ALCO $31.99
  • Resistance Level
  • CHRS $0.82
  • ALCO $34.31
  • Average True Range (ATR)
  • CHRS 0.04
  • ALCO 0.82
  • MACD
  • CHRS 0.01
  • ALCO 0.02
  • Stochastic Oscillator
  • CHRS 99.23
  • ALCO 44.42

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

Share on Social Networks: